Optogenetic-controlled immunotherapeutic designer cells for post-surgical cancer immunotherapyNature CommunicationsOctober 26, 202210.1038/s41467-022-33891-9Cited by 48SaveCiteExport RISWatch citationsRelated PapersNo related papers foundPowered by citation graph analysis